BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 34808651)

  • 1. Anti-TIF-1α/γ Antibody-Positive Dermatomyositis Associated With Metastatic Prostatic Adenocarcinoma.
    Psomadakis CE; Maron SZ; Ng MJ; Kessler AJ; Bryce CH; Shanker VL; Scelsa SN
    J Clin Neuromuscul Dis; 2021 Dec; 23(2):100-104. PubMed ID: 34808651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoantibody to transcriptional intermediary factor-1β as a myositis-specific antibody: clinical correlation with clinically amyopathic dermatomyositis or dermatomyositis with mild myopathy.
    Ueda-Hayakawa I; Hamaguchi Y; Okiyama N; Motegi S; Yamaoka T; Miyake S; Higashi A; Okamoto H; Takehara K; Fujimoto M
    Br J Dermatol; 2019 Apr; 180(4):881-887. PubMed ID: 30120913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NanoString technology distinguishes anti-TIF-1γ
    Preusse C; Eede P; Heinzeling L; Freitag K; Koll R; Froehlich W; Schneider U; Allenbach Y; Benveniste O; Schänzer A; Goebel HH; Stenzel W; Radke J
    Brain Pathol; 2021 May; 31(3):e12957. PubMed ID: 34043263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paraneoplastic Dermatomyositis in a Patient with Metastatic Gastric Carcinoma.
    Pozharashka J; Dourmishev L; Rusinova D; Balabanova M; Miteva L
    Acta Dermatovenerol Croat; 2020 Aug; 28(2):120-122. PubMed ID: 32876041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oropharyngeal Dysphagia in Dermatomyositis: Associations with Clinical and Laboratory Features Including Autoantibodies.
    Mugii N; Hasegawa M; Matsushita T; Hamaguchi Y; Oohata S; Okita H; Yahata T; Someya F; Inoue K; Murono S; Fujimoto M; Takehara K
    PLoS One; 2016; 11(5):e0154746. PubMed ID: 27167831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dermatomyositis with anti-TIF-1γ antibodies as a presenting symptom of underlying triple-negative breast cancer: a case report.
    Kubeček O; Soukup T; Paulík A; Kopecký J
    BMC Cancer; 2016 Aug; 16(1):684. PubMed ID: 27561848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparison of clinical and immunological features between clinically amyopathic dermatomyositis and typical dermatomyositis].
    Gan YZ; Li YH; Zhang LH; Ma L; He WW; Jin YB; An Y; Li ZG; Ye H
    Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Dec; 52(6):1001-1008. PubMed ID: 33331305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antinuclear Matrix Protein 2 Autoantibodies and Edema, Muscle Disease, and Malignancy Risk in Dermatomyositis Patients.
    Albayda J; Pinal-Fernandez I; Huang W; Parks C; Paik J; Casciola-Rosen L; Danoff SK; Johnson C; Christopher-Stine L; Mammen AL
    Arthritis Care Res (Hoboken); 2017 Nov; 69(11):1771-1776. PubMed ID: 28085235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of radioimmunoprecipitation versus antigen-specific assays for identification of myositis-specific autoantibodies in dermatomyositis patients.
    Kang EH; Kuwana M; Okazaki Y; Lee EY; Lee YJ; Lee EB; Song YW
    Mod Rheumatol; 2014 Nov; 24(6):945-8. PubMed ID: 24670134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dermatomyositis associated with prostate adenocarcinoma with neuroendocrine differentiation.
    Minagawa H; Kawai T; Matsumoto A; Makino K; Sato Y; Nagasaka K; Tokura M; Tanaka N; Ito E; Yamada Y; Nakamura M; Yamada D; Suzuki M; Murata T; Kume H
    BMC Urol; 2021 Jan; 21(1):8. PubMed ID: 33413292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Oropharyngeal dysphagia as a first manifestation of dermatomyositis associated with colon cancer].
    Espinoza-Cobos JC; Pérez-Figueroa J; Zúñiga-Ahuet G; Dorantes MA; Grube-Pagola P; Ruíz-Juárez I; Remes-Troche JM
    Rev Gastroenterol Mex; 2010; 75(4):522-7. PubMed ID: 21169124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A systematic review of adult-onset clinically amyopathic dermatomyositis (dermatomyositis siné myositis): a missing link within the spectrum of the idiopathic inflammatory myopathies.
    Gerami P; Schope JM; McDonald L; Walling HW; Sontheimer RD
    J Am Acad Dermatol; 2006 Apr; 54(4):597-613. PubMed ID: 16546580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amyopathic and anti-TIF1 gamma-positive dermatomyositis: analysis of a monocentric cohort and proposal to update diagnostic criteria.
    Didona D; Juratli HA; Scarsella L; Keber U; Eming R; Hertl M
    Eur J Dermatol; 2020 Jun; 30(3):279-288. PubMed ID: 32666928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myositis-specific anti-155/140 autoantibodies target transcription intermediary factor 1 family proteins.
    Fujimoto M; Hamaguchi Y; Kaji K; Matsushita T; Ichimura Y; Kodera M; Ishiguro N; Ueda-Hayakawa I; Asano Y; Ogawa F; Fujikawa K; Miyagi T; Mabuchi E; Hirose K; Akimoto N; Hatta N; Tsutsui K; Higashi A; Igarashi A; Seishima M; Hasegawa M; Takehara K
    Arthritis Rheum; 2012 Feb; 64(2):513-22. PubMed ID: 21987216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-transcription intermediary factor 1 gamma (TIF1γ) antibody-positive dermatomyositis associated with ascending colon cancer: a case report and review of the literature.
    Ono R; Kumagae T; Igasaki M; Murata T; Yoshizawa M; Kitagawa I
    J Med Case Rep; 2021 Mar; 15(1):142. PubMed ID: 33745453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lambert-Eaton Myasthenic Syndrome and Dermatomyositis With Anti-TIF1-gamma Autoantibody: A Unique Association of Autoimmune Neuromuscular Conditions Without Malignancy.
    Isfort M; Mnatsakanova D; Oddis C; Lacomis D
    J Clin Neuromuscul Dis; 2021 Mar; 22(3):164-168. PubMed ID: 33596001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of serum levels of anti-transcriptional intermediary factor 1-γ antibody in patients with dermatomyositis.
    Ikeda N; Yamaguchi Y; Kanaoka M; Ototake Y; Akita A; Watanabe T; Aihara M
    J Dermatol; 2020 May; 47(5):490-496. PubMed ID: 32103537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Presence of anti-transcriptional intermediary factor-1 gamma antibodies in a dermatomyositis patient with retroperitoneal cancer of unknown primary site.
    Hori H; Ozeki Y; Kobashigawa T; Futsuhara K; Tanaka A; Watanabe E; Yabe H; Yago T; Fukuchi T; Sugawara H; Kotake S
    Mod Rheumatol Case Rep; 2021 Jan; 5(1):62-68. PubMed ID: 33269651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myositis autoantibodies in Korean patients with inflammatory myositis: anti-140-kDa polypeptide antibody is primarily associated with rapidly progressive interstitial lung disease independent of clinically amyopathic dermatomyositis.
    Kang EH; Nakashima R; Mimori T; Kim J; Lee YJ; Lee EB; Song YW
    BMC Musculoskelet Disord; 2010 Sep; 11():223. PubMed ID: 20875136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A fatal case of dermatomyositis with underlying metastatic esophageal adenocarcinoma.
    Harrison BA; Heck SI; Hood AF
    Cutis; 2008 Jan; 81(1):26-8. PubMed ID: 18306844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.